oleanolic acid has been researched along with Hepatitis C, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Asai, K; Chayama, K; Hayes, CN; Hiraga, N; Imamura, M; Kawaoka, T; Maekawa, T; Matsuhira, T; Mitsui, F; Murakami, S; Ochi, H; Takahashi, S; Tateno, C; Tsuge, M; Yamashita, N; Yoshizato, K | 1 |
| Imazeki, F | 1 |
| Yamada, G | 1 |
2 review(s) available for oleanolic acid and Hepatitis C, Chronic
| Article | Year |
|---|---|
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Iron, Dietary; Liver Neoplasms; Oleanolic Acid; Phlebotomy; Prognosis; Ribavirin; Time Factors | 2004 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
1 other study(ies) available for oleanolic acid and Hepatitis C, Chronic
| Article | Year |
|---|---|
ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Topics: Animals; Antiviral Agents; Base Sequence; Cell Line; Disease Models, Animal; Drug Synergism; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; In Vitro Techniques; Interferon Type I; Mice; Mice, SCID; Oleanolic Acid; Recombinant Proteins; Replicon; RNA, Viral; Transplantation Chimera; Virus Replication | 2011 |